| Metal-based nanoparticles as antimicrobial agents: an overview E Sánchez-López, D Gomes, G Esteruelas, L Bonilla, AL Lopez-Machado, ... Nanomaterials 10 (2), 292, 2020 | 1037 | 2020 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1016 | 2022 |
| Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model A Cano, M Ettcheto, JH Chang, E Barroso, M Espina, BA Kühne, ... Journal of Controlled Release 301, 62-75, 2019 | 247 | 2019 |
| Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: In vitro and in vivo characterization E Sánchez-López, M Ettcheto, MA Egea, M Espina, A Cano, AC Calpena, ... Journal of nanobiotechnology 16, 1-16, 2018 | 213 | 2018 |
| Current applications of nanoemulsions in cancer therapeutics E Sánchez-López, M Guerra, J Dias-Ferreira, A Lopez-Machado, ... Nanomaterials 9 (6), 821, 2019 | 177 | 2019 |
| Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents EB Souto, J Dias-Ferreira, A López-Machado, M Ettcheto, A Cano, ... Pharmaceutics 11 (9), 460, 2019 | 161 | 2019 |
| PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen—In vitro, ex vivo and in vivo characterization E Sánchez-López, MA Egea, A Cano, M Espina, AC Calpena, M Ettcheto, ... Colloids and surfaces B: biointerfaces 145, 241-250, 2016 | 135 | 2016 |
| Microemulsions and nanoemulsions in skin drug delivery EB Souto, A Cano, C Martins-Gomes, TE Coutinho, A Zielińska, AM Silva Bioengineering 9 (4), 158, 2022 | 109 | 2022 |
| Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases A Cano, E Sanchez-Lopez, M Ettcheto, A Lopez-Machado, M Espina, ... Nanomedicine 15 (12), 1239-1261, 2020 | 89 | 2020 |
| Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy A Cano, M Ettcheto, M Espina, C Auladell, AC Calpena, J Folch, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (4), 1073-1085, 2018 | 83 | 2018 |
| Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery EB Souto, JF Fangueiro, AR Fernandes, A Cano, E Sanchez-Lopez, ... Heliyon, 2022 | 78 | 2022 |
| Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges A Cano, P Turowski, M Ettcheto, JT Duskey, G Tosi, E Sánchez-López, ... Journal of nanobiotechnology 19 (1), 122, 2021 | 76 | 2021 |
| ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker PR Manzine, M Ettcheto, A Cano, O Busquets, E Marcello, S Pelucchi, ... Biomedicine & Pharmacotherapy 113, 108661, 2019 | 76 | 2019 |
| Psoriasis: from pathogenesis to pharmacological and nano-technological-based therapeutics RG Petit, A Cano, A Ortiz, M Espina, J Prat, M Muñoz, P Severino, ... International journal of molecular sciences 22 (9), 4983, 2021 | 65 | 2021 |
| Dexibuprofen biodegradable nanoparticles: One step closer towards a better ocular interaction study E Sánchez-López, G Esteruelas, A Ortiz, M Espina, J Prat, M Muñoz, ... Nanomaterials 10 (4), 720, 2020 | 62 | 2020 |
| Epigallocatechin-3-Gallate (EGCG) improves cognitive deficits aggravated by an obesogenic diet through modulation of unfolded protein response in APPswe/PS1dE9 mice M Ettcheto, A Cano, PR Manzine, O Busquets, E Verdaguer, ... Molecular neurobiology 57, 1814-1827, 2020 | 60 | 2020 |
| State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections A Cano, M Ettcheto, M Espina, A López-Machado, Y Cajal, F Rabanal, ... Journal of nanobiotechnology 18, 1-24, 2020 | 57 | 2020 |
| Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia M Ettcheto, J Olloquequi, E Sanchez-Lopez, O Busquets, A Cano, ... Frontiers in aging neuroscience 11, 344, 2020 | 56 | 2020 |
| The involvement of peripheral and brain insulin resistance in late onset Alzheimer’s dementia J Folch, J Olloquequi, M Ettcheto, O Busquets, E Sanchez-Lopez, A Cano, ... Frontiers in aging neuroscience 11, 236, 2019 | 56 | 2019 |
| Zieli nska EB Souto, R da Ana, SB Souto probe 337, 275-281, 2007 | 50* | 2007 |
Eliana B SoutoFaculty of Pharmacy of University of Porto在 ff.up.pt 的电子邮件经过验证
